Attorney Fred Pritzker and his Bad Bug Law Team are investigating cases of meningitis in Tennessee and 9 other states that have been associated with lumbar epidural steroid injections using preservative-free methylprednisolone acetate prepared by New England Compounding Center (NECC), located in Framingham, MA. Several of the meningitis victims also suffered strokes, and some septic arthritis. At least 6 people have died in Tennessee, the state hardest hit by the outbreak, with 39 CDC-confirmed cases to date.
Fred recently won over $40,000,000 for clients injured by another defective medical product. He can be reached for a free consultation here.
To date 119 people in 10 states have been sickened in this outbreak of meningitis caused by a fungus (Exserohilum, Aspergillus fumigatus and possibly other fungi). Most people sickened in Tennessee were infected with Exserohilum. Many of them were treated at one outpatient surgical center/pain management clinic in Nashville, Saint Thomas Outpatient Neurosurgery Center. PCA Pain Care Center in Oak Ridge, TN and Specialty Surgery Center in Crossville, TN also received the steroid injections compounded by NECC.
At least 11 people sickened by the steroid-related meningitis have died nationwide. Families can contact Fred regarding a wrongful death lawsuit. Fred has won multimillion dollar amounts for meningitis wrongful death.
Meningitis Outbreak Investigation
All infected patients that are part of this outbreak received injection with preservative-free methylprednisolone acetate made (compounded) by the New England Compounding Center (NECC), according to the CDC. This is epidemiological evidence that can be used in a lawsuit against NECC to link the company’s product to the meningitis outbreak.
Exserohilum and Aspergillus fumigatu are the fungi that have caused the meningitis. Fred and his Bad Bug Law Team are working to determine how the NECC steroids were contaminated with them.
List of Recalled Products Related to Fungal Meningitis Outbreak
Methylprednisolone Acetate (original recall)
- Methylprednisolone Acetate (PF) 80 mg/ml – LOT# 05212012@68; 06292012@26; 06292012@26
Expansion of Methylprednisolone Acetate recall
- Methylprednisolone Acetate (PF) 40 mg/ml, Lot #05012012@74, 06082012@63, 07052012@34, 08132012@38,
- Methylprednisolone Acetate (P) 40 mg/ml, Lot #04242012@91, 06272012@7, 08082012@103
- Methylprednisolone Acetate (PF) 80 mg/ml, Lot # 04162012@108, 05012012@74, 06082012@63, 07052012@34, 08132012@38
- Methylprednisolone Acetate (P) 80 mg/ml, Lot #04062012@44, 05222012@13, 07302012@72
Sterile intrathecal products recall by NECC
- Betamethasone repository (PF) 6 mg/ml – ALL LOTS
- Betamethasone repository (P) 6 mg/ml – ALL LOTS
- Betamethasone sodiumphosphate (PF) 6 mg/ml – ALL LOTS
- Betamethasone sodium phosphate (P) 6 mg/ml – ALL LOTS
- Betamethasone sodiumphosphate (PF) 8 mg/ml – ALL LOTS
- Betamethasone sodiumphosphate (PF) 12 mg/ml – ALL LOTS
- Bupivicaine (PF) 0.25% – ALL LOTS
- Bupivicaine(PF) 0.5% – ALL LOTS
- Bupivicaine(PF) 0.75 – ALL LOTS
- Clonidine (PF) 100 mcg/ml – ALL LOTS
- Dexamethasone sodiumphosphate (PF) 4 mg/ml – ALL LOTS
- Dexamethasone sodiumphosphate(PF) 6 mg/ml – ALL LOTS
- Dexamethasone sodiumphosphate(PF) 8 mg/ml – ALL LOTS
- Dexamethasone sodiumphosphate(PF) 10 mg/ml – ALL LOTS
- Glycerin (PF) 100% – ALL LOTS
- Hyaluronidase (PF) 150 u/ml – ALL LOTS
- lsovue (PF) 200 mg/ml – ALL LOTS
- lsovue (PF) 300 mg/ml – ALL LOTS
- Lidocaine/Dextrose (PF) 5%/7.5% – ALL LOTS
- Lidocaine (PF) 1% – ALL LOTS
- Lidocaine (PF) 2% – ALL LOTS
- Lidocaine (PF) 4% – ALL LOTS
- Omnipaque (PF) 240mg/ml – ALL LOTS
- Omnipaque (PF) 300mg/ml – ALL LOTS
- Saline (PF) 10% – ALL LOTS
- Saline (PF) 3% – ALL LOTS
- Triamcinolone – 10 mg/ml (P) – ALL LOTS
- Triamcinolone – 40 mg/ml (PF) – ALL LOTS
- Triamcinolone – 40 mg/ml (P) – ALL LOTS
- Triamcinolone – 80 mg/ml (PF) – ALL LOTS
